Wolfgang Andreas Weber


Ontology type: schema:Person     


Person Info

NAME

Wolfgang Andreas

SURNAME

Weber

Publications in SciGraph latest 50 shown

  • 2022-06-30 Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2022-05-03 The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy in EJNMMI RESEARCH
  • 2022-04-04 Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0 in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2022-03-28 Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients in BMC CANCER
  • 2022-02-05 Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer in RADIATION ONCOLOGY
  • 2022-02-04 Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3 in EJNMMI RESEARCH
  • 2022-01-31 Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy in EJNMMI RESEARCH
  • 2022-01-31 Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma in EJNMMI RESEARCH
  • 2022-01-10 Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT in BRITISH JOURNAL OF CANCER
  • 2021-08-21 Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients in EJNMMI RESEARCH
  • 2021-08-21 PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy in EJNMMI RESEARCH
  • 2021-07-13 The added value of PSMA PET/MR radiomics for prostate cancer staging in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2021-07-08 PET and PET-CT in Treatment Response Evaluation: Overview in ATLAS OF CLINICAL PET-CT IN TREATMENT RESPONSE EVALUATION IN ONCOLOGY
  • 2021-07-07 Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2021-05-05 A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2021-04-15 Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04 in JOURNAL OF NUCLEAR CARDIOLOGY
  • 2021-04-01 Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo in SCIENTIFIC REPORTS
  • 2021-02-04 Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy—a multi-centre evaluation of 2533 patients in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2021-01-23 Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions in EJNMMI RADIOPHARMACY AND CHEMISTRY
  • 2020-07-28 Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patients in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2020-06-28 Clinical PET/MR in MOLECULAR IMAGING IN ONCOLOGY
  • 2020-05-06 Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2020-04-20 First In-Human Medical Imaging with a PASylated 89Zr-Labeled Anti-HER2 Fab-Fragment in a Patient with Metastatic Breast Cancer in NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2020-04-01 Imaging CXCR4 Expression with Iodinated and Brominated Cyclam Derivatives in MOLECULAR IMAGING AND BIOLOGY
  • 2020-02-03 Pre-test 68Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model in EJNMMI RESEARCH
  • 2020-01-17 Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-12-07 Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-12-02 Evaluation of SUV normalized by lean body mass (SUL) in 68Ga-PSMA11 PET/CT: a bi-centric analysis in EJNMMI RESEARCH
  • 2019-11-22 Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-09-07 Correction to: 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-08-19 Stellenwert der FDG-PET/Computertomographie beim kolorektalen Karzinom in DIE RADIOLOGIE
  • 2019-08-15 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-07-29 Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines in BMC CANCER
  • 2019-07-04 Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-01-21 Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 68Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques in EJNMMI RESEARCH
  • 2018-12-20 Die Rolle der Positronenemissionstomographie bei Gliomen in DIE ONKOLOGIE
  • 2018-12-19 Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenoma in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-11-28 Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-10-29 Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-09-21 Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET in RADIATION ONCOLOGY
  • 2018-08-29 Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET in RADIATION ONCOLOGY
  • 2018-07-04 Discriminating radiation injury from recurrent tumor with [18F]PARPi and amino acid PET in mouse models in EJNMMI RESEARCH
  • 2018-01-19 Trends in oncologic hybrid imaging in EUROPEAN JOURNAL OF HYBRID IMAGING
  • 2018-01-12 Target engagement imaging of PARP inhibitors in small-cell lung cancer in NATURE COMMUNICATIONS
  • 2017-11-22 A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas in JOURNAL OF NEURO-ONCOLOGY
  • 2017-07-10 Erratum to: Repeatability of [68Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate Cancer in MOLECULAR IMAGING AND BIOLOGY
  • 2017-05-23 Imaging in Oncology Research in SMALL ANIMAL IMAGING
  • 2017-05-22 Repeatability of [68Ga]DKFZ11-PSMA PET Scans for Detecting Prostate-specific Membrane Antigen-positive Prostate Cancer in MOLECULAR IMAGING AND BIOLOGY
  • 2017-05-01 Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-04-18 Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.6936.a", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7497.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411663.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1008.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410607.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15474.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412282.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6582.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.480278.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5963.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10388.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410569.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.19006.3e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4488.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412689.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.16872.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4367.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.66875.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6190.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412966.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.214572.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413734.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7708.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.430790.9", 
            "type": "Organization"
          }
        ], 
        "familyName": "Weber", 
        "givenName": "Wolfgang Andreas", 
        "id": "sg:person.01342726600.01", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-7854-4345"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342726600.01", 
          "https://orcid.org/0000-0002-7854-4345"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-11-24T21:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/person/person_724.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01342726600.01'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01342726600.01'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01342726600.01'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01342726600.01'


     

    This table displays all metadata directly associated to this object as RDF triples.

    71 TRIPLES      11 PREDICATES      38 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01342726600.01 schema:affiliation N39c9c28137134a3aaf64c687195d335f
    2 grid-institutes:grid.1008.9
    3 grid-institutes:grid.10388.32
    4 grid-institutes:grid.15474.33
    5 grid-institutes:grid.16872.3a
    6 grid-institutes:grid.19006.3e
    7 grid-institutes:grid.214572.7
    8 grid-institutes:grid.410569.f
    9 grid-institutes:grid.410607.4
    10 grid-institutes:grid.411663.7
    11 grid-institutes:grid.412282.f
    12 grid-institutes:grid.412689.0
    13 grid-institutes:grid.412966.e
    14 grid-institutes:grid.413734.6
    15 grid-institutes:grid.430790.9
    16 grid-institutes:grid.4367.6
    17 grid-institutes:grid.4488.0
    18 grid-institutes:grid.480278.1
    19 grid-institutes:grid.51462.34
    20 grid-institutes:grid.5386.8
    21 grid-institutes:grid.5963.9
    22 grid-institutes:grid.6190.e
    23 grid-institutes:grid.6582.9
    24 grid-institutes:grid.66875.3a
    25 grid-institutes:grid.7497.d
    26 grid-institutes:grid.7708.8
    27 schema:familyName Weber
    28 schema:givenName Wolfgang Andreas
    29 schema:identifier Nf3eb9ea8f8b34079b4623b46e80d8463
    30 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342726600.01
    31 https://orcid.org/0000-0002-7854-4345
    32 schema:sdDatePublished 2022-11-24T21:36
    33 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    34 schema:sdPublisher Nb064dd95f3fe4e8a80c9beeac184b6cf
    35 sgo:license sg:explorer/license/
    36 sgo:sdDataset persons
    37 rdf:type schema:Person
    38 N39c9c28137134a3aaf64c687195d335f schema:affiliation grid-institutes:grid.6936.a
    39 sgo:isCurrent true
    40 rdf:type schema:OrganizationRole
    41 Nb064dd95f3fe4e8a80c9beeac184b6cf schema:name Springer Nature - SN SciGraph project
    42 rdf:type schema:Organization
    43 Nf3eb9ea8f8b34079b4623b46e80d8463 schema:name orcid_id
    44 schema:value 0000-0002-7854-4345
    45 rdf:type schema:PropertyValue
    46 grid-institutes:grid.1008.9 schema:Organization
    47 grid-institutes:grid.10388.32 schema:Organization
    48 grid-institutes:grid.15474.33 schema:Organization
    49 grid-institutes:grid.16872.3a schema:Organization
    50 grid-institutes:grid.19006.3e schema:Organization
    51 grid-institutes:grid.214572.7 schema:Organization
    52 grid-institutes:grid.410569.f schema:Organization
    53 grid-institutes:grid.410607.4 schema:Organization
    54 grid-institutes:grid.411663.7 schema:Organization
    55 grid-institutes:grid.412282.f schema:Organization
    56 grid-institutes:grid.412689.0 schema:Organization
    57 grid-institutes:grid.412966.e schema:Organization
    58 grid-institutes:grid.413734.6 schema:Organization
    59 grid-institutes:grid.430790.9 schema:Organization
    60 grid-institutes:grid.4367.6 schema:Organization
    61 grid-institutes:grid.4488.0 schema:Organization
    62 grid-institutes:grid.480278.1 schema:Organization
    63 grid-institutes:grid.51462.34 schema:Organization
    64 grid-institutes:grid.5386.8 schema:Organization
    65 grid-institutes:grid.5963.9 schema:Organization
    66 grid-institutes:grid.6190.e schema:Organization
    67 grid-institutes:grid.6582.9 schema:Organization
    68 grid-institutes:grid.66875.3a schema:Organization
    69 grid-institutes:grid.6936.a schema:Organization
    70 grid-institutes:grid.7497.d schema:Organization
    71 grid-institutes:grid.7708.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...